Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine

16. August 2012

Abstract: Newborn screening for tyrosinemia type I (Tyr-I) is mandatory to identify infants at risk before life-threatening symptoms occur....

Read more

The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis

23. Februar 2012

Background: To determine the predictive value of the immature granulocyte count and the immature myeloid information in neonatal early onset...

Read more

Neonatal screening for lysosomal storage disorders: Feasibility and incidence from a nationwide study in Austria

29. November 2011

Background: The interest in neonatal screening for lysosomal storage disorders has increased substantially because of newly developed enzyme replacement...

Read more

Simplified newborn screening protocol for lysosomal storage disorders

1. September 2011

BACKGROUND: Interest in lysosomal storage disorders, a collection of more than 40 inherited metabolic disorders, has increased because of new...

Read more

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

1. März 2011

ABSTRACT: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative...

Read more

The national Austrian newborn screening program – eight years experience with mass spectrometry. past, present, and future goals

15. Oktober 2010

BACKGROUND: the National Austrian Newborn Screening Program for inherited metabolic and endocrinologic disorders was introduced in 1966. The program continuously...

Read more

Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of alpha-L-iduronidase mutations causing mucopolysaccharidosis type I

29. November 2009

Background: Mutations in the alpha-l-iduronidase A (IDUA) gene cause mucopolysaccharidosis type I (MPS I), a progressive multisystem disorder with...

Read more